Loading...
Development of a Neisseria meningitidis group B serotype 2b protein vaccine and evaluation in a mouse model.
Although serotype 2 remains the predominant cause of group B Neisseria meningitidis disease in many parts of the world, most cases of this disease are now due to serotype 2b rather than 2a. For this reason, we adapted the serotype 2a vaccine method of C. E. Frasch and M. S. Peppler (Infect. Immun. 3...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
1984
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC261547/ https://ncbi.nlm.nih.gov/pubmed/6437983 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|